Trehalose Administration in Subjects With Spastic Paraplegia 11 (3AL-SPG11)

Clinical trial NCT04912609 · COMPLETED

Trial details

NCT number: NCT04912609
Sponsor: IRCCS Fondazione Stella Maris
Status: COMPLETED
Study type: OBSERVATIONAL

Hereditary Spastic Paraplegia Spastic Paraplegia Type 11

Start date: 2021-06-30
Primary completion: 2022-04-30
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.